Terms & Conditions

As the last step before payment, you are asked to submit a photograph of a government-issued photo ID and a self-portrait photograph of your face (a “selfie”). We transmit those images to our third-party identity-verification provider, which checks the authenticity of the identity document and confirms that the person in the selfie is the person shown on the document.

• Teledris Health does not store your ID or selfie images. They are held only for the duration of the check and transmitted to our identity-verification provider and, where a program requires it for the clinical record, to your treating clinician's platform.
• We do retain a record of the check itself: its outcome, our provider's reference identifier, the date and time, the document type and the name, date of birth, document number and expiration date read from your ID, the score and result of the facial comparison, and any risk warnings our provider returned. We keep this as the audit record that you were verified.
• If your identity cannot be verified, you are not charged, no authorization is captured, and no medication is dispensed. Any amount charged in error is refunded in full.
• Your identity-verification provider processes these images as our service provider, under its own retention and security practices.

The check described above includes an automated comparison of your selfie against the portrait printed on your identity document. That comparison analyzes facial characteristics and may constitute the collection, use, or disclosure of biometric information or a biometric identifier under the laws of certain states.

By submitting your ID and selfie, you consent to Teledris Health and its identity-verification provider collecting and using your facial image and any facial-comparison data derived from it for the sole purpose of verifying your identity, preventing fraud, and satisfying our legal and clinical obligations. We do not sell this information, do not use it for advertising, and do not use it to identify you for any other purpose.

If you do not wish to have your facial image processed in this way, do not submit a selfie — but you will not be able to complete an order, because the check is required. To ask questions about this processing, or to request deletion of the verification record we retain, contact support@teledris.com.

1. Patient Intake: You complete a medical intake providing your health history, current medications, allergies, symptoms, and other relevant clinical information, and you select the treatment you are requesting.
2. Identity Verification: You complete the identity check described in Section IV.
3. Payment Authorization: You submit payment details. Depending on your program, we either place an authorization hold or securely save your card. In both cases, you are not charged before a clinician approves treatment — see Section X.
4. Clinician Review:Your intake is reviewed by an independent licensed healthcare provider within the provider network facilitated by our telehealth services partner for your program. Reviews are typically completed within 24 hours but may take longer depending on volume and complexity. Your clinician may ask you for additional information before deciding — for example a photo of your driver's license, a short introductory video, an updated answer to a clinical question, additional documents, or your pharmacy preference. We will notify you when something is needed, and your case will not progress until you provide it.
5. Clinical Decision: The reviewing provider determines, at their sole discretion, whether to prescribe medication based on your clinical profile. A prescription is not guaranteed.
6. Prescription Fulfillment: If a prescription is issued, your clinical services partner transmits it to a licensed partner pharmacy, including compounding pharmacies, which dispenses the medication and ships it directly to your address. We will keep you updated as your order is prepared, ships, and is delivered.
7. Ongoing Care: Follow-up consultations, clinician messaging, and monitoring are provided as part of your treatment plan, as described below.

Continuing treatment is not automatic. Before each new treatment cycle, we ask you to complete a short follow-up check-in so your clinician can confirm that continued treatment at the same dose remains appropriate. We notify you by email — and by SMS if you have opted in — when a follow-up is due.

• Each new cycle is reviewed by a clinician, and is charged only after that cycle is approved (see Section X).
• If you do not complete your follow-up, your treatment does not continue, no further medication is dispensed, and you are not charged for that cycle.
• Your clinician may change your dose, strength, or formulation at any follow-up, or may determine that continued treatment is no longer appropriate.

Some programs require laboratory testing before or during treatment. Testosterone replacement therapy, in particular, generally requires bloodwork.

• Depending on your state and your clinician's order, testing is performed either by an at-home collection kit shipped to you, or in person at a patient service center or laboratory draw site.
• Where in-person collection is required — which is the case in some states because at-home collection is not available there — you may be required to travel to and appear physically at a laboratory. This is an exception to the otherwise remote nature of the Services.
• We notify you as your lab order progresses, including when a kit ships, when your sample is received, and when results are available.
• Where a laboratory requires a requisition form, it is made available to you through your patient portal, and you can upload lab results you obtained elsewhere for your clinician to review.
• Failing to complete required laboratory testing may delay or prevent treatment.

Some programs require or offer a live video visit with a clinician in addition to or instead of asynchronous review. Where a video visit applies to your care, we will notify you to schedule it and provide a booking link. You may reschedule. Missing a scheduled visit without rescheduling may delay or prevent treatment.

Parts of your intake are evaluated automatically before a clinician sees them. Clinicians designate certain answers in advance as disqualifying for a given treatment on safety grounds. If you give such an answer, our system ends the visit at that point — before any payment is taken — and tells you that we cannot treat you through this program.

This automated screen is a safety guardrail, not a medical opinion about you, and it does not mean a clinician has reviewed your case. You are not charged when a visit ends this way. If you believe the screen reached the wrong result, contact support@teledris.com.

• No guarantee of prescription. The decision to prescribe medication is at the sole discretion of the treating provider based on clinical judgment and applicable medical guidelines.
• Primarily remote care. Most Teledris Health consultations are conducted asynchronously — you submit information and a clinician reviews it without a live appointment. Some programs and states additionally require a live video visit, and some require in-person laboratory collection. We do not perform physical examinations, and certain conditions may require in-person evaluation we cannot provide.
• Controlled substances. Certain therapies (such as testosterone) involve controlled substances and are prescribed only where permitted under the federal Ryan Haight Act, U.S. Drug Enforcement Administration telemedicine rules, and applicable state law, which may require additional identity verification, laboratory testing, a live video visit, or an in-person evaluation.
• Not a replacement for primary care. We strongly recommend maintaining an ongoing relationship with a primary care provider.

By purchasing a treatment plan through Teledris Health, you agree to pay the fees associated with your selected service as displayed on the Platform at the time of purchase. All fees are in U.S. dollars.

For our cash-pay programs, the price shown is for your medication plan and includes clinical review, provider messaging, and shipping at no additional charge. We do not bill a separate consultation fee. Pricing varies by service and treatment plan.

All payments are processed securely through our third-party payment processor, Stripe. Teledris Health does not collect or store your full credit card details.

You are never charged before a licensed clinician reviews your intake and approves treatment. How that works depends on your program:

• Authorization hold. For our GLP-1 weight-loss plans and our one-time purchase programs, when you submit your order your card is authorized — a temporary hold is placed for the amount of your plan — but you are not charged. The hold becomes a charge only when a clinician approves treatment. If treatment is not approved, or if you cancel before approval, the hold is released and you are not charged.
• Saved card, billed on approval. For our other recurring programs, including testosterone replacement therapy, no hold is placed. Instead your card is securely saved with Stripe and an unpaid invoice is created for your first cycle. No money moves at that time. The invoice is paid only after a clinician approves treatment; if treatment is not approved, the invoice is voided and you are not charged.

In both cases, if a clinician declines to prescribe after your card has already been charged, we refund the charge in full automatically — you do not need to request it.

Card networks release an unused authorization hold after approximately seven days. If clinical review has not completed before your hold expires and treatment is subsequently approved, we will charge the card you provided at checkout for that approved treatment without placing a new hold. This is why we save your card, as described below. You are never charged more than the amount shown to you at checkout, and you are never charged if treatment is not approved.

Your clinician may prescribe a different strength, dose, or formulation than the one you selected at checkout. When that happens:

• You are never charged more than the amount you authorized at checkout. If your clinician prescribes a plan that would cost more, we do not charge you the difference.
• Where your plan is billed by authorization hold, we capture only the price of the plan your clinician approved — so if it costs less than you authorized, you are charged the lower amount.
• Where your first cycle is billed by invoice, that cycle is billed at the amount shown to you at checkout.
• The same ceiling applies to each ongoing cycle: the amount you authorize for a cycle is the maximum you can be charged for that cycle.

When you check out, your payment card is saved by Stripe for future use on your account. We do so in order to:

• Charge your approved treatment if your authorization hold expires before clinical review completes;
• Bill your ongoing treatment cycles after each cycle is approved; and
• Allow you to enroll in an additional Teledris Health program without re-entering your card, by billing that program to the same payment profile.

Teledris Health never receives or stores your full card number. You can add and remove saved cards yourself in your patient portal, or contact support@teledris.com. Removing a saved card does not cancel your plan — if you remove the card your plan bills to, your next cycle's charge will fail rather than your treatment stopping cleanly. To end a plan, cancel it as described below.

Most treatment plans continue in recurring cycles — for example a new medication shipment every four weeks — until you cancel. If you enroll in a recurring plan:

• Your plan automatically renews at the then-current price and billing interval until you cancel. We obtain your affirmative consent to these subscription terms at checkout, disclose the recurring amount and frequency before you are charged, and send any notices required by applicable automatic-renewal laws.
• You authorize recurring charges to your saved payment method at the frequency specified at the time of enrollment.
• Each cycle requires a follow-up check-in and clinician approval before it is billed (see Section VI). A cycle you do not complete a follow-up for is not shipped and not charged.
• We notify you by email — and by SMS if you have opted in — when a follow-up is due for your next cycle.
• Your plan continues at the then-current price for your prescribed treatment, subject to the authorization ceiling described above, until you cancel.
• Charges are processed automatically once a cycle is approved, unless you cancel before that cycle is billed.
• You may cancel at any time from your patient portal, or by contacting us at support@teledris.com.

• Before clinician approval: Your card is only authorized or saved, not charged. If you cancel before a clinician approves your treatment — or if a clinician determines treatment is not appropriate for you — the hold is released or the invoice is voided, and you are not charged.
• After approval, before shipment: Once a clinician approves your treatment and your card is charged, you may request a refund of the medication cost any time before your medication ships.
• After medication shipment: Once your medication has shipped, it is non-refundable, because compounded medications are prepared specifically for you and cannot be returned or reused.
• Cancelling a recurring plan: Cancellation stops future cycles. A cycle that has already been approved and charged is not reversed by cancelling, and we do not prorate or refund partial billing periods.

Our Refund Policy sets out these rules in full, including damaged, lost, or misshipped orders. To request a cancellation or refund, contact support@teledris.com.

We send messages that are necessary to deliver your care and operate your account. These include:

• Sign-in links and one-time codes needed to access your account and portal.
• Requests for information your clinician needs before deciding — for example a photo of your driver's license, a short introductory video, an updated clinical answer, additional documents, or your pharmacy preference.
• Clinical status updates, including when your case is assigned to a clinician, when your clinician is waiting on you, when your treatment is being processed, when a prescription is written, and when your visit is complete.
• Order and shipping updates, including when your order is in fulfillment, in transit, out for delivery, delivered, or has a delivery problem.
• Laboratory updates, including when a collection kit ships or is delivered, when your sample is shipped or received, and when results are available.
• Video visit updates, including when a visit is ready to schedule, is scheduled, is rescheduled, or was missed.
• Follow-up reminders when a new treatment cycle is due.
• Messages sent to you by your clinician or our support team.
• Account, billing, and service notices, and — where you have not opted out — promotional materials.

Messages about your care and your account are transactional and are sent regardless of marketing preferences, because they are necessary to provide the Services you requested. We may also contact you by telephone about your treatment or account.

If you opt in, Teledris Health may send recurring and non-recurring SMS/text messages to the mobile number you provide for the care-related and account purposes described above, including clinician requests for information, action-required clinical status updates, follow-up reminders, appointment scheduling and reminders, care coordination, and account notifications. Message frequency varies. Message and data rates may apply. Reply STOP to opt out and HELP for help. Consent to receive SMS is not required to create an account, make a purchase, or receive healthcare services.

Your patient portal includes a message thread with your care team. Messages you exchange there with clinicians and support staff form part of your record, are retained with your case, and may be reviewed by the clinicians and clinical-services partners involved in your care. Do not use portal messaging for emergencies — see Section II.

You may opt out of marketing emails by using the unsubscribe link. You may opt out of SMS/text messages at any time by replying STOP. After you opt out of SMS, Teledris Health may contact you through other available channels for important account, transactional, or care-related communications. You cannot opt out of the transactional and care-related messages needed to deliver treatment while you have an active plan; if you no longer wish to receive them, cancel your plan.

We use cookies and similar technologies on our website:

• A cookie that keeps you signed in to your account.
• Attribution cookies that record how you first reached our site — marketing campaign parameters, advertising click identifiers passed to us by ad platforms, and the referring website. We associate that information with your record in our customer relationship system.
• A tracking script provided by HighLevel (also operating as LeadConnector), the customer relationship and messaging platform we use, which records page visits and interactions across our website so we can attribute inquiries and measure engagement with our own services.
• A chat widget provided by the same platform, which loads on our marketing pages. It is not loaded inside the intake funnel.
• A traffic-analytics service provided by our website hosting provider, used to measure aggregate site usage.
• A cookie set by Stripe, our payment processor, to detect and prevent fraud.

What we do not do. We do not use third-party advertising pixels, such as the Meta Pixel, and we do not use Google Analytics. We do not sell your personal information, and we do not share it with third parties for cross-context behavioral advertising or targeted advertising. Advertising click identifiers travel one way — we receive them when you arrive from an ad, and we do not send information about you back to any advertising platform.

Our Privacy Policy describes these technologies, your browser-level choices, and your rights in more detail.

Before initiating any formal dispute resolution proceeding, you agree to first contact Teledris Health at support@teledris.com and attempt to resolve the dispute informally for at least thirty days.

This arbitration agreement is governed by the Federal Arbitration Act. If we cannot resolve a dispute informally, any dispute, claim, or controversy arising out of or relating to these Terms or your use of the Platform shall be resolved by binding arbitration administered by the American Arbitration Association in accordance with its Consumer Arbitration Rules, rather than in court.

Arbitration shall take place in Miami-Dade County, Florida, or at another mutually agreed location. The arbitrator's decision shall be final and binding and may be entered as a judgment in any court of competent jurisdiction.

YOU AND TELEDRIS HEALTH AGREE THAT EACH PARTY MAY BRING CLAIMS AGAINST THE OTHER ONLY IN YOUR OR ITS INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS ACTION, COLLECTIVE ACTION, OR REPRESENTATIVE PROCEEDING. The arbitrator may not consolidate more than one person's claims and may not otherwise preside over any form of a representative or class proceeding.

You may opt out of this arbitration agreement and class action waiver within thirty days of first accepting these Terms by sending written notice of your decision to opt out to support@teledris.com with your name and the email associated with your account. If you opt out, neither party will be required to arbitrate, and this Section will not apply.

Notwithstanding the above, either party may seek injunctive or equitable relief in a court of competent jurisdiction for claims relating to intellectual property infringement or misappropriation. Nothing in this Section waives any right to seek public injunctive relief to the extent such a waiver is prohibited by applicable law, including under California law.